0001209191-21-035149.txt : 20210521 0001209191-21-035149.hdr.sgml : 20210521 20210521210855 ACCESSION NUMBER: 0001209191-21-035149 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210520 FILED AS OF DATE: 20210521 DATE AS OF CHANGE: 20210521 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Muralidhar Bali CENTRAL INDEX KEY: 0001784138 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39594 FILM NUMBER: 21950915 MAIL ADDRESS: STREET 1: C/O EXICURE, INC. STREET 2: 8045 LAMON AVENUE, SUITE 410 CITY: SKOKIE STATE: IL ZIP: 60077 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SPRUCE BIOSCIENCES, INC. CENTRAL INDEX KEY: 0001683553 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 812154263 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2001 JUNIPERO SERRA BLVD., SUITE 640 CITY: DALY CITY STATE: CA ZIP: 94104 BUSINESS PHONE: (415) 294-1687 MAIL ADDRESS: STREET 1: 2001 JUNIPERO SERRA BLVD., SUITE 640 CITY: DALY CITY STATE: CA ZIP: 94104 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-05-20 0 0001683553 SPRUCE BIOSCIENCES, INC. SPRB 0001784138 Muralidhar Bali C/O ABINGWORTH BIOVENTURES 38 JERMYN STREET LONDON X0 SW1Y6DN UNITED KINGDOM 1 0 0 0 Stock Option (Right to Buy) 15.24 2021-05-20 4 A 0 10000 0.00 A 2031-05-19 Common Stock 10000 10000 D The shares vest on the first anniversary of the Grant Date, provided that the Option will in any case be fully vested on the date of Company's 2022 annual stockholder meeting, subject to the Reporting Person's Continuous Service (as defined in the 2020 Equity Incentive Plan (the "Plan")) through such vesting date and will vest in full upon a Change in Control (as defined in the Plan). Samir Gharib, Attorney-in-Fact 2021-05-21